Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  Chao, Yuan Chang ^a,b   Huang, Ching Shan ^c   Lee, Chun Nan ^a,b   Chang, Sui Yuan ^a,b   King, Chwan Chuen ^b   Kao, Chuan Liang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASIA; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE ASSOCIATION; ENDEMIC DISEASE; EX VIVO STUDY; FLOW CYTOMETRY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HUMAN CELL; MALE; MONOCYTE; MONONUCLEAR CELL; PATHOGENESIS; SEROTYPE; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS TRANSMISSION; CASE CONTROL STUDY; CELL CULTURE; PATHOGENICITY; VIROLOGY;

DENGUE VIRUS;

CASE-CONTROL STUDIES; CELLS, CULTURED; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MONOCYTES;

EID: 45349097665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001557     Document Type: Article

References (32)

1. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-496.
2. Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10: 100-103.
3. Gubler DJ (2004) The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis 27: 319-330.
4. Scott RM, Nisalak A, Cheamudon U, Seridhoranakul S, Nimmannitya S (1980) Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 141: 1-6.
5. Chen YC, Wang SY, King CC (1999) Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol 73: 2650-2657.
6. Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, Lai JH (2001) Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 166: 1499-1506.
7. Halstead SB (1989) Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 11 Suppl 4: S830-S839.
8. Reeves EP, Lu H, Jacobs HL, Messina CG, Bolsover S, Gabella G, Potma EO, Warley A, Roes J, Segal AW (2002) Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291-297.
9. Beutler E (1994) G6PD, deficiency. Blood 84: 3613-3636.
10. Mchta A, Mason PJ, Vulliamy TJ (2000) Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol 13: 21-38.
11. WHO Working Group (1989) Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 67: 601-611.
12. Iwai K, Hirono A, Matsuoka H, Kawamoto F, Horie T, Lin K, Tantular IS, Dachlan YP, Notopuro H, Hidayah NI, Salim AM, Fujii H, Miwa S, Ishii A (2001) Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia. Hum Genet 108: 445-449.
13. Chiang SH, Wu SJ, Wu KF, Hsiao KJ (1999) Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan. Southeast Asian J Trop Med Public Health 30 Suppl 2: 72-74.
14. Mamlok RJ, Mamlok V, Mills GC, Daeschner CW III, Schmalstieg FC, Anderson DC (1987) Glucose-6-phosphate dehyorogenase deficiency, neutrophil dysfunction and Chromobacterium, violaceum sepsis. J Pediatr 111: 852-854.
15. Vives Corrons JL, Feliu E, Pujades MA, Cardellach F, Rozman C, Carreras A, Jou JM, Vallespi MT, Zuazu FJ (1982) Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (C6PD Barcelona). Blood 59: 428-434.
16. Gotsman I, Muszkat M (2001) Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A. J Gastroenterol Hepatol 16: 1239-1243.
17. Gray GR, Stamatoyannopoulos G, Naiman SC, Kliman MR, Klebanoff SJ, Austin T, Yoshida A, Robinson GC (1973) Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet 2: 530-534.
18. Abu-Osba YK, Mallouh AA, Hann RW (1989) Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr 114: 748-752.
19. Costa E, Vasconcelos J, Santos E, Laranjeira A, Castro e Melo, Barbot J (2002) Neutrophil dysfunction in a case of glucose-6-phosphate dehydrogenase deficiency. J Pediatr Hematol Oncol 24: 164-165.
20. Tanphaichitr VS, Chonlasin R, Suwantol L, Pung-Amritt P, Tachavanich K, Yogsan S, Viprakasit V (2002) Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever. J Med Assoc Thai 85 Suppl 2: S522-S529.
21. King CC, Wu YC, Chao DY, Lin TH, Lin C, Wang HT, Ku CC, Kao CL, Chien LJ, Chang HJ, Huang JH, Twu SJ, Huang KP, Lam SK, Gubler DJ (2000) Major Epidemics of Dengue in Taiwan in 1981-2000: Related to Intensive Virus Activities in Asia in 1981-2000: Related to Intensive Virus Activities in Asia. Dengue Bulletin 24: 1-10.
22. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH, King CC (2003) High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305: 330-338.
23. Hayes JM, Rigau-Perez JG, Reiter P, Effler PV, Pang L, Vorndam V, Hinten SR, Mark KE, Myers MF, Street K, Bergau L, Meyer C, Amador M, Napier M, Clark GG, Biggerstaff BJ, Gubler DJ (2006) Risk factors for infection during a dengue-1 outbreak in Maui, Hawaii, 2001. Trans R Soc Trop Med Hyg 100: 559-566.
24. van Bruggen R, Bautista JM, Petropoulou T, de Boer M, van Zwieten R, Gomez-Gallego F, Belohradsky BH, Hartwig NG, Stevens D, Mason PJ, Roos D (2002) Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 100: 1026-1030.
25. Chen TP, Roberts RL, Wu KG, Ank BJ, Stiehm ER (1993) Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults. Pediatr Res 34: 544-550.
26. Lindgren H, Stenmark S, Chen W, Tarnvik A, Sjostedt A (2004) Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis. Infect Immun 72: 7172-7182.
27. Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, Ou JH (2004) Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma tells. Hepatology 39: 81-89.
28. Kwan WH, Helt AM, Maranon C, Barbaroux JB, Hosmalin A, Harris E, Fridman WH, Mueller CG. (2005) Dendritic cell precurson are permissive to dengue virus and human immunodeficiency virus infection. J Virol 79: 7291-7299.
29. Lafleur C, Granados J, Vargas-Alarcon G, Ruiz-Morales J, Villarreal-Garza C, Higuera L, Hernandez-Pacheco G, Cutino-Moguel T, Rangel H, Figueroa R, Acosta M, Lazcano E, Ramos C (2002) HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HIA-DR4 as a possible genetic resistance factor for-dengue hemorrhagic fever. Hum Immunol 63: 1039-1044.
30. Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC (2002) Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Gastroenterology 123: 127-133.
31. Kung CM, King CC, Lee CN, Huang LM, Lee PI, Kao CL (2007) Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J Med Virol 79: 60-68.
32. Kao CL, Wu MC, Chiu YH, Lin JL, Wu YC, Yueh YY, Chen LK, Shaio MF, King CC (2001) now cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture. J Clin Microbiol 39: 3672-3677.